Ramses Erdtmann
Founder chez BIOMEA FUSION, INC.
Fortune : 31 M $ au 31/03/2024
Profil
Mr. Rainer M.
Erdtmann is a President, Chief Operating Officer & Director at Biomea Fusion, Inc., a Managing Member at Point Sur Investors LLC, a Managing Director at Oxygen Investments LLC and a President at Biomea Health LLC.
He is on the Board of Directors at Biomea Fusion, Inc.
Prior to forming Point Sur Investors, from 2008-2016, Mr. Erdtmann was with Pharmacyclics, Inc., a Nasdaq-listed biotech company.
He began as Vice President, Finance & Administration, Corporate Secretary and acted as the Principal Financial and Accounting Officer.
In that capacity he was responsible for accounting, SEC reporting, audits, and investor relations.
He built and had operational responsibility for Finance, IT, HR, Legal, Facilities, and Events.
He later served as Executive Vice President of Corporate Affairs including Corporate Communications.
Additionally, he structured and administered the international revenue for Pharmacyclics into a swiss-based subsidiary.
He also actively participated in the final execution of key corporate milestones for Pharmacyclics, among them the Collaboration Agreement with J&J in 2011 (value $1.0 Billion) and the merger agreement with AbbVie in 2015 (value $21 Billion).
Prior to Pharmacyclics, he worked as an asset manager and investment banker, representing European and US institutional investors, family offices and high net worth investors.
He began his career at Commerzbank, Germany, where he was an investment banker and portfolio manager for institutional international accounts.
He earned the Diplom Kaufmann degree, with honors, in Finance and Banking from the Westfaelische Wilhelms Universitaet Muenster, Germany.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOMEA FUSION INC
5,75% | 17/01/2024 | 2 052 030 ( 5,75% ) | 31 M $ | 31/03/2024 |
Postes actifs de Ramses Erdtmann
| Sociétés | Poste | Début |
|---|---|---|
| BIOMEA FUSION, INC. | Founder | 01/08/2017 |
Point Sur Investors LLC
 Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Founder | 01/01/2015 |
| Biomea Health LLC | Founder | - |
Anciens postes connus de Ramses Erdtmann
| Sociétés | Poste | Fin |
|---|---|---|
| REGENETP, INC. | Director/Board Member | 23/03/2020 |
| PHARMACYCLICS, INC. | Director of Finance/CFO | 21/08/2012 |
| Oxygen Investments LLC | Founder | 01/01/2009 |
Robert W. Duggan & Associates
 Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 01/01/2008 |
Robert W. Duggan & Associates
Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 01/01/2001 |
Formation de Ramses Erdtmann
| University of Münster | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| COMMERZBANK AG | Finance |
| REGENETP, INC. | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Robert W. Duggan & Associates
Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Finance |
| United Properties Immobilien & Anlagen GmbH | |
| Commerz International Capital Management GmbH | |
Point Sur Investors LLC
Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Finance |
| Biomea Fusion, Inc. | |
| Biomea Health LLC | |
| Oxygen Investments LLC |
